The objective of this study was t o design DNA probe sets that enable the detection of chromosome aberrations in acute myeloid leukemia (AML) by interphase cytogenetics using fluorescence in situ hybridization (FISH) and t o compare the results of interphase cytogenetics with those of conventional chromosome banding analysis. One hundred five consecutive patients with adult AML entered on a multicenter treatment trial were studied with a comprehensive set of DNA probes recognizing the most relevant AMLassociated structural and numerical chromosome aberrations: translocations t(8;21), t(15;17), and t ( l lq23); inversion inv(l6); chromosomal deletions (5q-, 7q-, 9q-, 12p-, 13q-, 17p-, and 20q-); and chromosomal aneuploidies. Interphase cytogenetics was particularly sensitive for detecting the AML-specific gene fusions: 3 additional cases of inv(l6) and 1 additional case of t(8;21) were identified by FISH that were missed by banding analysis, whereas equal N ACUTE MYELOID leukemia (AML), a large number I of chromosome aberrations have been identified that, in part, define distinct biologic subgroups of The molecular characterization of these aberrations has confirmed that genes important in cellular proliferation and differentiation are affected by these chromosome aberrations.' In retrospective and prospective treatment trials, it has been shown that these chromosome aberrations are one of the most important predictive factors for response rates and remission duration^.^^^^' Furthermore, subgroups of leukemias defined by specific chromosome aberrations may benefit from certain chemotherapeutic agents in postremission therapy.' Thus, cytogenetic analysis has become of great importance for the management of patients with AML.
The objective of this study was t o design DNA probe sets that enable the detection of chromosome aberrations in acute myeloid leukemia (AML) by interphase cytogenetics using fluorescence in situ hybridization (FISH) and t o compare the results of interphase cytogenetics with those of conventional chromosome banding analysis. One hundred five consecutive patients with adult AML entered on a multicenter treatment trial were studied with a comprehensive set of DNA probes recognizing the most relevant AMLassociated structural and numerical chromosome aberrations: translocations t(8;21), t(15;17), and t ( l lq23); inversion inv(l6); chromosomal deletions (5q-, 7q-, 9q-, 12p-, 13q-, 17p-, and 20q-); and chromosomal aneuploidies. Interphase cytogenetics was particularly sensitive for detecting the AML-specific gene fusions: 3 additional cases of inv(l6) and 1 additional case of t(8;21) were identified by FISH that were missed by banding analysis, whereas equal N ACUTE MYELOID leukemia (AML), a large number I of chromosome aberrations have been identified that, in part, define distinct biologic subgroups of The molecular characterization of these aberrations has confirmed that genes important in cellular proliferation and differentiation are affected by these chromosome aberrations. ' In retrospective and prospective treatment trials, it has been shown that these chromosome aberrations are one of the most important predictive factors for response rates and remission duration^.^^^^' Furthermore, subgroups of leukemias defined by specific chromosome aberrations may benefit from certain chemotherapeutic agents in postremission therapy.' Thus, cytogenetic analysis has become of great importance for the management of patients with AML.
Chromosome banding analyses have been the standard method for the identification of chromosome aberrations. However, chromosome banding studies may be hampered by poor chromosome morphology, low proliferative activity of the leukemic cells, reduced cell viability after transport to the reference laboratory, or the complexity of the karyotype. More recently, molecular genetic techniques, such as Southem blot analysis or reverse transcriptase-polymerase chain numbers of t(llq23) and t115;17) were detected. Five additional cases of trisomy 8q. 3 more cases of trisomy 1 Iq, and 2 more cases of trisomies 21q and 22q were shown by FISH. These aberrations were either masked in complex karyotypes or identified in cases in which conventional banding analysis failed. On the other hand, the DNA probes selected were not informative t o detect 1 case of 5q-, 9q-, and20q-. In 5 cases, clonal aberrations were detected on banding analysis for which no FISH probes were selected. In conclusion, interphase cytogenetics proved t o be more sensitive for detecting AML-specific chimeric gene fusions and some partial trisomies. Interphase cytogenetics provides a powerful technique complementary and, with further development of diagnostic DNA probes, even an alternative t o chromosome banding studies for the cytogenetic analysis of AML.
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reaction (RT-PCR), have been used for the detection of the AML-specific translocations or inversion, allowing for a precise molecular diagnosis and monitoring of minimal residual disease.'-" However, these techniques are restricted to the detection of a few aberrations.
In recent years, fluorescence in situ hybridization (FISH) techniques have increasingly been used for the cytogenetic analysis of leukemia.".I3 Compared with conventional cytogenetic analysis, FISH permits the identification of chromosome aberrations in interphase cells, referred to as interphase cytogenetic^.'^ With the developments in the Human Genome Project, a large variety of DNA probes have now become available that allow hybridization to DNA sequences of different complexity. These include probes recognizing tandem repeat sequences in the centromeric or pericentromeric regions and probes cloned in phage, cosmid, P1, PI artificial chromosome (PAC), or yeast artificial chromosome (YAC) clones that recognize single copy sequence^."^'^ In principle, all numerical and structural chromosome aberrations can be detected by FISH provided that suitable probes from the corresponding regions are available.
So far, cytogenetic studies using FISH have been limited to the detection of chromosome aneuploidies using centromere-specific DNA probes'*," or the identification of specific translocations in small numbers of However, the applicability of FISH as a method for comprehensive interphase cytogenetic analysis of a specific leukemia has not yet been shown. The objective of this study was to design DNA probe sets that enable the detection of AML-relevant structural and numerical chromosome aberrations and to compare this interphase cytogenetic approach with conventional chromosome banding analysis in a large series of consecutive patients with adult AML. and interphase cytogenetic analysis. All patients were entered on a German multicenter treatment trial (AML HD93) in which postremission therapy is stratified according to the karyotype. At diagnosis, bone marrow and blood samples were sent to our laboratory from all 10 participating institutions. Fifty-two patients were male and 53 were female. The ages ranged from 16 to 60 years (median, 43 years). Ninety-five patients had de novo AML, and 10 patients had secondary AML after a primary malignancy. Leukemias were classified according to French-American-British (FAB) criteria.26 G-banding analysis was performed using standard methods and the karyotypes were designated according to the International System for Cytogenetic Nomenclature." Table 1 gives a summary of the DNA clones that we used for the detection of AML-associated chromosome aberrations by interphase cytogenetics.
DNA Probes
For the detection of the t(8; 21), we used a pool of two partially overlapping YAC clones, 464H8 and 72H9, recognizing AMLl and AMLI-flanking sequences2* and a differently labeled PI-phage clone (P1 164) containing the entire E T 0 gene.25 Because the breakpoints of the t(8;21) occur in the 5' region of the ET0 gene, the PI-phage clone identifies the derivative chromosome 8. Two criteria were required for the identification of the t(8;21) in interphase nuclei: (1) 1 l) , cohybridization was performed with two overlapping cosmid clones, 48 and 55, recognizing AF9 sequences distally flanking the break~oint.~' To distinguish between t(l lq23) and partial trisomy of llq, we used two differently labeled YAC clones, 785E12 and 856B9,I6 flanking the MLL gene proximally and distally, respectively. In cases with + 1 Iq, three juxtaposed signals will be seen, whereas in t( 1 lq23), one juxtaposed signal will be on the normal chromosome 11 and separate red and green signals will be on the der( 11) and the translocation partner, respectively. For the detection of inv(l6), we used YAC clone 854E2; this clone spans the breakpoint cluster region in the MYHll gene in band 16~13." The CEFP-MYHII gene fusion was shown by cohybridization of YAC 854E2 with cosmid clones LA2-2 and LA4-1 spanning the breakpoints in the CEFP gene on band 16q22.23 Translocatiodinversion screening was performed using a single probe, ie, 464H8/72H9 pool for t(8;21), 356C12 for t(l5; 17), 13HH4 and 785C6/856B9 for t(l lq23), and 854E2 for inv(l6). Chimeric genes were subsequently shown by cohybridization with the respective DNA probe.
Aneuploidies/deletions. The following monosomies, trisomies, and deletions were detected by interphase cytogenetics (clone designation, chromosomal localization, and gene/DNA marker are given in parenthesis): -/+X (A24CH4; Xq28; DXS304)33; -/+Y (yOX-57; Yq11)34; -5/5q-(773D3; 5q31; D5S89'6; and yPR411; 5q33; CSFIR)"; -7/7q-(HSC7E506; 7q22; D7S24d5; and HSC7E124; 7q3.5; D7S688)35; +8/8q+ (935A12; 8q24; D8S5O8)l6; -9/9q-(253F8; 9q13-21; D9S15)36; 1 2~-(964ClO 12~13; TEL)I6; 13q-/ pool; 17~13; TP53)38; -20/20q-(808C05; 2Oq13; D2OS99)l6; +21/ +13q (REI phage clones; 13q14; -17/17p-(TP53 cosmid +21q (464H8172H9 pool; 21q22; AML1)I6; +22/+22q (D107F9; 22qlI; ECR).z4,39
Preparation of DNA Clones
Cosmid and P1 phage DNA was prepared according to the plasmid MIDI KIT protocol (Qiagen, Hilden, Germany). Human sequences from YAC clones were generated by a PCR protocol using primers directed against Alu sequences. Amplification was performed in a 100 pL reaction mixture containing approximately 160 ng YAC-DNA, 100 mmol/L of the four dNTPs (Boehringer Mannheim, Mannheim, Germany), IO pL PCR buffer (Boehringer Mannheim), and 2.0 mmom MgC12 (Boehringer Mannheim). Three Alu-PCR reactions were performed using the primers CL1, CL2, or a combination of both (0.5 pmol/L).40 The products of all three reactions were combined for the FISH experiments. DNA from YAC clone 854E2, purified by pulsed-field gel electrophoresis, and from REI phage clones were amplified using the sequence-independent amplification (SIA) protocol."' The probes were labeled by nick translation with biotin-16-dUTP or digoxigenin-1 1 -dUTP (Boehringer Mannheim).
Interphase Cytogenetics
Slides prepared from methanouacetic acidfixed cell pellets were dehydrated in a series of ethanol and stored at -20°C. After thawing, the slides were incubated with pepsin (1 mg pepsin in 100 mL 0.01 m o m HCL; Serva, Heidelberg, Germany) for 5 minutes at 37°C and postfixed in 2% paraformaldehyde (Sigma, Deisenhofen, Germany).
The hybridization mixture contained approximately 250 ng labeled YAC, cosmid, or P1 phage DNA; 10 pg Cot-1 DNA Slide preparation.
FISH.
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RESULTS

G-Banding Analysis
Evaluable metaphase cells were found in 95 of 105 (91%) cases. The number of metaphase cells analyzed ranged from 5 to 34 (median, 15). Of the 95 evaluable cases, 51 (54%) had clonal chromosome aberrations and 44 had a normal karyotype. When considering all 105 patients, clonal chromosome aberrations were detected in 49% (45 of 105) of the cases ( Table 2 ). The distribution of chromosome aberrations according to specific aberrations is shown in Table 3 and Fig I . 
Interphase Cytogenetics
To define the cutoff levels for the diagnosis of the specific chromosome aberrations, hybridization experiments to blood specimens from 5 probands were performed for each DNA probe or probe set. When screening for monosomies or deletions, the two probes that were cohybridized served as the mutual internal control for hybridization efficiency. By analogy to our previous studies on deletion analyses in B-cell chronic lymphocytic leukemia, the cutoff level was defined by the mean + 3 standard deviations (SD) of the frequency of control cells exhibiting only one fluorescence ~i g n a l .~' .~~ Using these criteria, the cutoff levels for the diagnosis of monosomies or deletions ranged between 3.3% and 7.5%. For the diagnosis of trisomies, the cutoff levels ranged between 1.1 % and 4.1 %. For the detection of the AML-specific chimeric gene products, two or three criteria were required (Fig 2) : splitting of one YAC signal and one or two colocalizations of YAC with cosmid or PI signals. Using these criteria, the percentage of false-positive cells was less than 1% for the detection of the t(8;21), the t(15;17), and the t(9;ll). These data are comparable to those of our previous report on the detection of the t(9;22) in ALL and chronic myeloid leukemia.24 The sensitivity for the identification of inv(l6) was lower (6%) due to the higher degree of decondensation of the target DNA detected by YAC 854E2 (Fig 2C) . This was improved Dejinition of cutoff levels.
by the use of YAC 854E2 DNA amplified by SIA-PCR instead of Alu-PCR, resulting in better coverage of the target DNA. To consider the hybridization properties of the test cells, we also determined the cutoff level for each probe on 12 leukemic samples, which on chromosome banding analysis exhibited a normal karyotype. These cutoff levels were very similar to those derived from normal control cells (monosomies/deletions, 4.2% to 7.3%; trisomies, 2.4% to 3.6%).
Comparison of Metaphase and Interphase Cytogenetic Analysis
In contrast to chromosome banding analysis, all 105 cases were evaluable by interphase cytogenetics. In general, 6 to 8 slides were necessary to hybridize all 23 DNA probes. By interphase cytogenetics, chromosome aberrations were detected in 53 of 105 (51%) cases (Table 2) . A comparison of the results between metaphase and interphase analysis for specific aberrations is shown in Table 3 and Fig I . The complete G-banding and FISH karyotypes are given in Table  4 .
By interphase cytogenetics, more cases of inv( l6), t(8;21), +8q, + l l q , +21q, +22q, and -Y were detected. Inv(l6) was identified in 8 cases by banding analysis and in 1 I cases by interphase cytogenetics. The fluorescence signal pattern characteristic of the inv(l6) was seen in only 21% to 47% (median, 30%) of the cells in the 11 cases with an inv( 16) (Fig 2C) . These lower percentages were most likely due to the probe characteristics and not to low numbers of cells carrying the inversion. The 3 additional cases identified by FISH included 1 case (no. 13) that exhibited a 5q-as the sole chromosome aberration in 3 of 15 (20%) metaphase cells analyzed, a second case (no. 52) with a normal karyotype, and a third case (no. 54) in which no evaluable metaphase cells were obtained. Retrospective analysis of the first and second cases showed that the inv( 16) was likely present but was missed due to poor chromosome morphology. In accordance with this finding, a split signal was found on one chromosome 16 homolog in both cases by metaphase FISH. All 1 I cases with inv(l6) were confirmed by RT-PCR (data not shown). All t(X:21) cases found on banding analysis were also identified by interphase cytogenetics (Fig 2A) . One case of a variant t(X:21) (no. 21)-designated 46,XX,add(2)(pI 3).add(2 1 )(q22) on banding analysis-was only detected by interphase cytogenetics. All cases with trisomy 8 (+X/+Xq) identified by banding analysis were also detected by interphase cytogenetics. In case no. 2. 53% of the interphase cells exhibited three signals with the chromosome 8 probe, whereas using banding analysis. only 2 of 20 (10%) metaphase cells had trisomy X. Five additional cases of +8q were found by FISH: in 1 case. a subclone of +8q (no. 28) was masked in a complex karyotype, whereas in the 4 other cases (nos. 54. 55, 57. and 58), there were no evaluable metaphase cells. Furthermore. additional cases of + I l q (nos. 28, 56, and 57). +21q (nos. 1 and 57). +22q (nos. 1 and 7). and -Y (nos. 13 and 53) were detected by interphase cytogenetics. On banding analysis. these aberrations were either masked in complex karyotypes or no evaluable metaphase spreads were obtained. In case no. 7, multiple fluorescence signals were seen with the chromosome 22-specific probe: using metaphase FISH. the signals were localized to the marker chromosomes that were found on banding analysis. In case no. 33, multiple signals were seen with the YAC-contig from band 1 lq23 that, using metaphase FISH, were mapped to the ring chromosome.
In contrast, I additional case of 5q-(no. 26). 9q-(no. 3). and 20q-(the latter in a highly complex karyotype: case no. 28) was identified by chromosome banding analysis. Of the 12 cases with -5/5q-on banding analysis, 1 1 cases were identified by interphase cytogenetics. All cases had deletion of both loci tested. ie. DSS89 (identified by clone 773D3) and CSFIR (identified by clone yPR41 I). One case (no. 26) that had a 5q-in a complex karyotype on banding analysis was not detected by interphase cytogenetics. Metaphase FISH showed that chromosome 5 material was translocated to chromosome 19 and not deleted. The D5S89 locus was retained on the der(5). whereas the CSFIR gene was translocated to the der( 19). indicating that a break had occurred between 11.5389 and the CSFIR gene.
Eight cases oft( 1 lq23) were detected by banding analysis: 6 cases of t(9: 1 I)(p21;q23): I t( 11: 17)(q23:q21): and 1 t(1O: I I)(plI or 13;q23). AI1 cases of t(9: I I). but not the latter two translocations, were identified by FISH using YAC clone 13HH4 (Fig 2E) . The t( 1 1; 17) (case no. 17) and t( IO: 1 I ) (case no. 34) were only detected when using the pool of YAC clones 785C6 and 856B9. A split signal was observed in 75% and 25% of the cells. respectively (see the Discussion). The low percentage of cells with three signals in case no. 34 suggests that a large interstitial deletion had occurred that resulted in a loss of target sequences recognized by the probe DNA. All 6 cases of t( 15: 17) detected by banding analysis were identified by FISH. Eight cases of -7/7q-detected by banding analysis were identified by interphase cytogenetics: 7 cases had deletion of the two loci analyzed. D7S240 (7922) and D7S688 (7q35), whereas 1 case (no. 35) had deletion of the distal locus only (Fig 2D) . Similarly, all cases of 17p-on banding analysis were detected by FISH. One additional case of 7q-and of 17p-was found in a leukemia (no. 57) without evaluable metaphase cells on banding analysis.
Coses with clorinl nhermtioris detected I>y G-hnndirig nrzrrlysis 01711'. Fifty-two cases had no aberrations by interphase cytogenetics. In 5 (nos. 47 through 51) of these cases, clonal chromosome aberrations were detected by banding analysis: ins(2; 3)(p22:q2 lq26): t(6:9)(p23:q34): t(3:8)(ql3.2:q24.1): der(l3: 14)(qIO:qlO): +14. All 5 aberrations occurred as single aberrations and could not be detected by the DNA probe sets selected for this study. found on banding analysis. In 5 (nos. 54 through 58) of these rapid and sensitive methods are needed because molecularcases, chromosome aberrations were detected by interphase based classification and treatment strategies are becoming cytogenetics, ie, 2 cases with +8q as sole aberration and 3 increasingly important. In our study, we have designed a
Cnses with n riorrnrrl k n n o t y w or1 G-hariclirig
For personal use only. on January 15, 2018. by guest www.bloodjournal.org From comprehensive set of DNA probes that allows sensitive molecular diagnosis of these chromosome aberrations by interphase cytogenetics. These diagnostic probes were validated in a series of 105 consecutive patients with AML enrolled on a multicenter treatment trial.
Interphase cytogenetics were particularly sensitive for the detection of chimeric genes that arise from the inv(l6), t(8;21) or t(l5; 17) (Fig 2) . Three additional cases of inv(l6) were identified by FISH using YAC clone 854E2. This clone, originally isolated for positional cloning of the p-arm b r e a k p~i n t ,~~ has recently been shown to be split by the inv( 16) in a series of 29 leukemias carrying the inversion.u This series included 5 leukemias that, in addition to the inversion, exhibited interstitial deletions of 150 to 350 kb in size proximal to the p-arm breakpoint cluster region. Hence, it is likely that YAC clone 854E2 identifies the vast majority, if not all cases of inv ( 16) . Interphase cytogenetics may even be more sensitive than RT-PCR in detecting the inv ( 16) . In at least three RT-PCR studies, cases were identified that cytogenetically showed the inv( 16) but lacked a CBFPMYHl I fusion transcript detectable by the PCR a~say.~'.~' By analogy, interphase cytogenetics allowed sensitive detection of the t(8;21) and t(l5; 17). In our study, there was 1 additional case of AMLI-ET0 fusion that was only detected by FISH. This fusion resulted from a variant t(8;21) that was not identified by chromosome banding analysis. Using RT-PCR, AMLI-ET0 fusion transcripts have also been identified in leukemias with morphologic features characteristic of the t(8; 2 1) but without the cytogenetic presence of the t(8;21).48 It is unknown whether the genomic DNA probes used in our study permit the identification of such cases, which presumably result from interstitial insertions. The diagnostic potential of the probes would depend on the size of the inserted fragment. Such an insertion has recently been shown by FISH in a case of microgranular variant of acute promyelocytic leukemia, which on banding analysis lacked the t(15; 17), but by FISH using cosmid probes for PML and RARA showed the juxtaposition of the two genes.49 Similarly, our study confirms the value of FISH for the diagnosis of the t(l5; 17). All cases that showed the t(l5; 17) on banding analysis were detected by FISH. Thus, FISH is a very efficient method in the diagnosis of both the AMLI-E T 0 fusion and of the PML-RARA fusion, which is important because of the high sensitivity of these leukemias to specific agents, ie, high-dose cytarabine and all-trans retinoic acid, respectively.
Only 6 of the 8 translocations involving band 1 lq23 identified on banding analysis were detected by FISH using the 440-kb YAC clone 13HH4 that contains the entire MLL gene. Two cases, a t(l0; 11) and a t(l1; 17), were only detected with a contig of YAC clones (785C6 and 856B9), recognizing more than 1.0 Mb of DNA sequences distal to the MLL gene in band llq23." This finding is not unexpected because interstitial deletions distal to the breakpoint, which may be several hundred kilobases in size, have been reported in up to 30% of t( 1 1q23).7,31,50 Thus, for the detection of t(l lq23) by FISH, it will be necessary to use a pool of YAC clones spanning these interstitial deletions. A large number of different partners have been shown to be involved in 1 lq23 trans location^.^ When using YAC clones from band 1 lq23 alone, one cannot distinguish between the different translocations. In the present study, we only used genomic clones for the detection of the most frequent translocation partner, which is the AF9 gene in the t(9; 11) ( Fig 2E) . Recently, more subtle rearrangements have been described, including interstitial insertions or partial internal duplications of the MLL gene?','* Because Southern blot analysis is unlikely to be performed on a routine basis, FISH and RT-PCR using multiple primers will presumably be the most efficient methods for detecting 1 lq23 abnormalities.
Interphase cytogenetics were also highly sensitive for detecting the most frequent chromosome deletions or aneuploidies. For deletion screening, we chose DNA probes recognizing genes or DNA loci known to be affected in myeloid leukemia, such as D5S89 or the CSFlR gene in -5/5q-,53 the TEL gene in or the TP53 gene in 17p-. For the identification of -7/7q-, 9q-, or 20q-, we selected probes that recognize DNA loci that map to the critical regions identified by chromosome banding analysis. All but 1 case of -5l5q-and all cases of -7l7q-were detected by interphase cytogenetics. In the 1 case that showed a 5q-in a complex karyotype on banding analysis, we could show by metaphase FISH that the 5q-resulted from an unbalanced translocation with the breakpoint between D5S89 and the CSFlR gene.
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For the detection of 7q-, it is important to use probes that recognize loci in the two critical regions on chromosome 7 that have been identified by banding analysis, 1 at band 7q22 and 1 at 7q32-q35.55 In our study; 8 of 9 cases with 7q-had deletion of both regions by FISH, whereas 1 case had deletion of the distal region only, resulting from an unbalanced t(7; 13) with loss of 7q34-qter (Fig 2D) . One case each of 9q-and 20q-, both within a complex karyotype, were not detected by FISH. One explanation is that the DNA loci tested for may not be located within the commonly deleted region. With the identification of the pathogenetically relevant genes and the generation of diagnostic DNA probes, deletions in the corresponding regions should be readily detected. Altematively, the chromosomal region may not have been deleted, but masked in complex chromosome changes. In contrast, more cases of trisomy Sq, 21q, and 22q were detected by FISH. These aberrations were either identified in cases without evaluable metaphases on banding analysis or in cases in which partial trisomies were presumably masked by complex karyotypes.
The DNA probe sets selected identify specific targeted chromosome regions and therefore will not detect all possible chromosome aberrations due to the molecular heterogeneity of AML. Accordingly, the aberrations identified by banding analysis could not be detected by FISH in 5 cases. Nevertheless, our study shows the power of interphase cytogenetics for detecting the most important chromosome aberrations in AML. Interphase cytogenetics proved to be more sensitive for detecting AML-specific translocations and inversion and provided a technique for the detection of chromosome aberrations in 5 of 10 cases in which no evaluable metaphases were found on banding analysis. With the applicability to a variety of materials, such as methanovacetic acid fixed cells from cytogenetic preparations or blood and bone marrow smears, interphase cytogenetics is an attractive method complementary and, with further development of diagnostic probes, alternative to conventional chromosome banding studies in multicenter treatment trials. In addition, interphase cytogenetics could be used for the monitoring of residual disease. Compared with PCR-based tests, current HSH protocols are less sensitive; however, they allow a quantification of cells carrying the aberration and the detection of chromosome abnormalities for which no PCR assays are available. For the translocations analyzed in our study, the percentage of false-positive cells was less than 1%. With such low cutoff levels and with recent developments of automated image analysis, the detection and quantification of residual disease will likely become clinically applicable.s6
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